Teriparatide Prevented Near Atypical Femur Fracture by Reducing Cortical Thickening in a Symptomatic Patient With Prolonged Use of Oral Bisphosphonate: A Case Report

Jaspinder Kaur, Luis Chavez, Issac Sachmechi, Paul Kim

Abstract


Long-term bisphosphonate (BP) treatment is associated with adverse event of atypical femur fracture (AFF) due to their long-lasting unique bone-seeking properties, and subsequent uptake by osteoclasts results in sustained inhibition of bone resorption even after their cessation. We report a case of postmenopausal women who presented with pain and severe femoral cortical thickening on alendronate for 10 years, but with no signs of obvious radiolucent fracture line on radiograph and bone marrow edema on magnetic resonance imaging representing impending AFF. Teriparatide (TPP) was started after discontinuation of BP which showed resolution of pain and reduction of femoral cortical thickness. We recommend biannual radiographs follow-up for evaluation of cortical thickening in patients taking BP along with the review of bone mineral density, and consideration of treatment with TPP if cortical thickening is present.




J Endocrinol Metab. 2016;6(6):183-186
doi: https://doi.org/10.14740/jem382w


Keywords


Atypical femur fracture; Bisphosphonate; Cortical thickening; Osteoporosis; Teriparatide

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

  

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

  

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

  

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

  

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

  
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.